Novus Animal Nutrition (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 4.00 Cr
- Company Age 15 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4.51%
- Profit Growth -58.90%
- Ebitda -50.74%
- Net Worth 2.81%
- Total Assets -30.02%
About Novus Animal Nutrition (India)
Novus Animal Nutrition (India) Private Limited (NANIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 25 January 2010 and has a history of 15 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nongluck Bunsong and Manish Singh serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U15400TN2010FTC074368
-
Company No.
074368
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
25 Jan 2010
-
Date of AGM
31 Oct 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Novus Animal Nutrition (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nongluck Bunsong
|
Director | 25-Aug-2023 | Current |
| Manish Singh | Additional Director | 18-Apr-2024 | Current |
Financial Performance of Novus Animal Nutrition (India).
Novus Animal Nutrition (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.51% increase. The company also saw a substantial fall in profitability, with a 58.9% decrease in profit. The company's net worth moved up by a moderate rise of 2.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novus Animal Nutrition (India)?
In 2023, Novus Animal Nutrition (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novus Animal Nutrition (India)?
Novus Animal Nutrition (India) has a workforce of 42 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novus Animal Nutrition (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novus Animal Nutrition (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
